How to Check Current GLP-1 Prescribing Information on DailyMed

To check the current prescribing information for a GLP-1 medicine, search the brand name on DailyMed (dailymed.nlm.nih.gov), choose the listing from the manufacturer (Novo Nordisk for Wegovy and Ozempic, Eli Lilly for Zepbound, Mounjaro and Foundayo), and look at the "Recent Major Changes" box and the revision date. That tells you what the label says today, not what it said when someone took a screenshot.

This matters more for GLP-1 medicines than almost any other drug class right now, because their labels have been changing fast. Here is how to do it properly. (If you are wondering what it means when a prescriber goes beyond the label, see off-label GLP-1 prescribing.)

Why do GLP-1 labels change so often?

New trials keep adding indications, new doses and new safety information. A few changes visible in current labels:

• Wegovy now lists a MASH (fatty liver disease) indication, a 7.2 mg maximum dose (Wegovy HD), and Wegovy tablets alongside the injection.
• Wegovy and Zepbound both show the "Suicidal Behavior and Ideation" warning as Removed in 02/2026, after FDA's January 2026 review.
• Zepbound added an update on diabetic retinopathy complications in people with type 2 diabetes in 08/2026.
• Mounjaro now includes children 10 and older with type 2 diabetes, and a heart-risk reduction indication for adults with type 2 diabetes at high risk.

If you read a post from 2024, it could be wrong on all of these. Not because anyone lied, but because the label moved.

Step by step: finding the current label on DailyMed

1. Go to dailymed.nlm.nih.gov. DailyMed is run by the National Library of Medicine and publishes labeling submitted to FDA.
2. Search the brand name, for example "Zepbound."
3. Pick the right listing. You may see more than one. Look at who it is from. When we searched in October 2026, "Wegovy" returned the Novo Nordisk listing (updated June 2026) and a second listing from a repackager, A-S Medication Solutions, last updated April 2024. That older listing does not include the MASH indication that the current Novo Nordisk label has. Same drug name, different snapshot in time.
4. Check the format. Some listings cover several forms. The current Wegovy listing covers both the injection and tablets, each with its own indications.
5. Open "Highlights of Prescribing Information" and find the Recent Major Changes box near the top. It lists which sections changed and the month and year.
6. Note the revision date ("Revised: MM/YYYY") and the date you looked.

Tip: the full listing also includes the Medication Guide and Instructions for Use at the end, each with its own revision date, so the dates can differ within one document.

What are the sections of a GLP-1 prescribing information?

Every U.S. prescription label follows the same numbered layout, which makes it much easier to jump to your answer.

Section	What it covers	Example question it answers
Boxed Warning	The most serious warning	What is the thyroid C-cell tumor warning?
1 Indications and Usage	What it is approved for, and limitations of use	Is it approved for teens? For sleep apnea?
2 Dosage and Administration	Doses, schedule, missed doses, switching	What does the label say about a missed dose? (Missed-dose rules by medicine)
4 Contraindications	Who should not use it	Who is it not for?
5 Warnings and Precautions	Important risks	Pancreatitis, gallbladder, kidney injury from dehydration
6 Adverse Reactions	Side effects seen in trials, with percentages	How common is nausea?
7 Drug Interactions	Effects on other medicines	Does it affect birth control pills?
8 Use in Specific Populations	Pregnancy, breastfeeding, children, older adults, kidney or liver problems	What about pregnancy?
14 Clinical Studies	The trials and their results	What did SELECT show?
17 Patient Counseling Information	What clinicians should tell patients	What should I watch for?

For example, if your question is "does Zepbound affect the pill?", go to section 7 and 8.3. The Zepbound label advises people using oral contraceptives to switch to a non-oral method, or add a barrier method, for 4 weeks after starting and for 4 weeks after each dose increase. That level of detail rarely survives into a social media summary. (Our dedicated post: tirzepatide and birth control pills.)

Which document is which?

• Prescribing Information (PI): the full technical label written for clinicians. This is "the label."
• Medication Guide: a plain-language FDA-approved handout for patients, usually included at the end.
• Instructions for Use (IFU): step-by-step pen or tablet instructions.

All three can be updated on different dates. If you are checking how to use your pen, the IFU is the one to read.

When DailyMed is not enough

• For label history, Drugs@FDA (on fda.gov) lists approval letters and past label versions, handy when you want to know when something changed.
• For safety updates that may not yet be in the label, check FDA's Drug Safety Communications. (How to read an FDA safety alert.)
• For anything about your own treatment, the label is the starting point, not the decision. Your prescriber and pharmacist interpret it for your situation.

A simple habit for saving labels

When you save or share a label, write three things next to it: brand and form (for example, "Wegovy injection"), the manufacturer, and the revision date. If you keep notes in an app like GLPily's journal, a one-line entry ("Checked Zepbound PI, revised 08/2026, section 7 on contraception") saves you hunting next time.

Common questions

Where can I find the official Wegovy or Zepbound prescribing information?

On DailyMed, by searching the brand name and choosing the manufacturer's listing. FDA's Drugs@FDA site also has label PDFs.

Why are there several DailyMed listings for the same GLP-1?

Repackagers and relabelers submit their own listings, and these can lag behind the manufacturer's current label. Use the manufacturer's listing and check the revision date.

What is the "Recent Major Changes" section?

A box in the Highlights that lists which label sections changed recently and when. It is the fastest way to see what is new.

Is the label the same as medical advice?

No. It describes what FDA approved and the known risks. How it applies to you is a conversation with your prescriber or pharmacist.